United Therapeutics Corporation Payments to Acquire Investments
United Therapeutics Corporation (UTHR) reported Payments to Acquire Investments of $145.70 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-04-26.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2017-04-26
- United Therapeutics Corporation payments to acquire investments for the quarter ending 2017-03-31 was $145.70M.
- United Therapeutics Corporation payments to acquire investments for the quarter ending 2016-12-31 was $28.40M.
- United Therapeutics Corporation payments to acquire investments for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- United Therapeutics Corporation payments to acquire investments for the quarter ending 2015-12-31 was $0.00.
- United Therapeutics Corporation payments to acquire investments for fiscal 2016 was $36.00M, a 33.58% decline from fiscal 2015.
- United Therapeutics Corporation payments to acquire investments for fiscal 2015 was $54.20M, a 20.44% increase from fiscal 2014.
- United Therapeutics Corporation payments to acquire investments for fiscal 2014 was $45.00M, a 46.27% increase from fiscal 2013.
- United Therapeutics Corporation payments to acquire investments for fiscal 2013 was $30.77M.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 6 month as first filed | Payments to Acquire Investments 9 month | Payments to Acquire Investments 9 month as first filed | Payments to Acquire Investments 12 month | Payments to Acquire Investments 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2017-03-31 | $145.70M 10-Q · filed 2017-04-26 | $174.10M derived: sum of 2 quarters · filed 2017-04-26 | $174.10M derived: sum of 3 quarters · filed 2017-04-26 | ||||
| 2016-12-31 | $28.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $28.40M derived: sum of 2 quarters · filed 2017-02-22 | $36.00M 10-K · filed 2017-02-22 | ||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | $7.60M 10-Q · filed 2016-10-27 | |||||
| 2016-06-30 | $7.60M 10-Q · filed 2016-07-28 | ||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $50.00M derived: sum of 2 quarters · filed 2017-02-22 | $54.20M 10-K · filed 2017-02-22 | $54.22M 10-K · filed 2016-02-25 | |||
| 2015-09-30 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | $54.20M 10-Q · filed 2016-10-27 | $54.22M 10-Q · filed 2015-10-27 | ||||
| 2015-06-30 | $4.20M 10-Q · filed 2016-07-28 | $4.22M 10-Q · filed 2015-07-28 | |||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $0.00 derived: sum of 2 quarters · filed 2017-02-22 | $45.00M 10-K · filed 2017-02-22 | ||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $45.00M 10-Q · filed 2015-10-27 | |||||
| 2014-06-30 | $45.00M 10-Q · filed 2015-07-28 | ||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $30.77M 10-K · filed 2016-02-25 | ||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $30.77M 10-Q · filed 2014-10-28 | |||||
| 2013-06-30 | $30.77M 10-Q · filed 2014-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |